TY - RPRT TI - Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study. AU - K Laczika AU - M Novak AU - B Hilgarth AU - M Mitterbauer AU - G Mitterbauer AU - A Scheidel-Petrovic AU - C Scholten AU - R Thalhammer-Scherrer AU - S Brugger AU - F Keil AU - I Schwarzinger AU - O A Haas AU - K Lechner AU - U Jaeger PY - 1998 DO - 10.1200/jco.1998.16.4.1519 UR - https://pubmed.ncbi.nlm.nih.gov/9552061/ ID - 9552061 ER -